News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
500,363 Results
Type
Article (37223)
Company Profile (105)
Press Release (463035)
Section
Business (148465)
Career Advice (1489)
Deals (28792)
Drug Delivery (102)
Drug Development (66410)
Employer Resources (116)
FDA (11732)
Job Trends (11515)
News (261087)
Policy (28128)
Tag
Academia (2317)
Alliances (50648)
Alzheimer's disease (1143)
Approvals (11687)
Artificial intelligence (135)
Bankruptcy (269)
Best Places to Work (9564)
Breast cancer (163)
Cancer (1229)
Career advice (1253)
CAR-T (89)
Cell therapy (260)
Clinical research (52635)
Collaboration (502)
Compensation (219)
COVID-19 (2581)
C-suite (97)
Data (1158)
Diabetes (153)
Diagnostics (5278)
Drug pricing (92)
Earnings (48037)
Employer resources (109)
Events (64874)
Executive appointments (289)
FDA (12300)
Funding (405)
Gene therapy (186)
GLP-1 (630)
Government (4265)
Healthcare (14998)
Infectious disease (2681)
Inflammatory bowel disease (91)
Interviews (244)
IPO (12476)
Job creations (2308)
Job search strategy (1080)
Layoffs (320)
Legal (7386)
Lung cancer (180)
Lymphoma (89)
Manufacturing (198)
Medical device (8416)
Medtech (8419)
Mergers & acquisitions (16477)
Metabolic disorders (438)
Neuroscience (1436)
NextGen Class of 2024 (5209)
Non-profit (3902)
Northern California (1316)
Obesity (255)
Opinion (195)
Parkinson's disease (92)
Patents (96)
People (39430)
Phase I (16253)
Phase II (23036)
Phase III (18010)
Pipeline (462)
Postmarket research (1936)
Preclinical (6889)
Radiopharmaceuticals (234)
Rare diseases (217)
Real estate (4002)
Regulatory (17858)
Research institute (2145)
Resumes & cover letters (223)
Southern California (1095)
Startups (3140)
United States (11387)
Vaccines (628)
Weight loss (202)
Date
Today (32)
Last 7 days (464)
Last 30 days (1877)
Last 365 days (28236)
2024 (28114)
2023 (32081)
2022 (41184)
2021 (44908)
2020 (43232)
2019 (37399)
2018 (28314)
2017 (25710)
2016 (24352)
2015 (28072)
2014 (20796)
2013 (16709)
2012 (17756)
2011 (18529)
2010 (16498)
Location
Africa (665)
Arizona (111)
Asia (31798)
Australia (5604)
California (2854)
Canada (1113)
China (262)
Colorado (135)
Connecticut (135)
Europe (74866)
Florida (401)
Georgia (105)
Illinois (309)
Indiana (175)
Maryland (573)
Massachusetts (2123)
Michigan (117)
Minnesota (185)
New Jersey (861)
New York (863)
North Carolina (569)
Northern California (1316)
Ohio (117)
Pennsylvania (665)
South America (915)
Southern California (1095)
Texas (410)
Washington State (272)
500,363 Results for "molecular partners ag".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Drug Development
Molecular Glue Degraders at Inflection Point as Pharma Dives In
Novartis, Biogen, Takeda and Novo Nordisk are all betting on advances in the molecular glue degraders space, collectively investing billions in hopes of treating cancer, Alzheimer’s disease, cardiometabolic disease and more.
December 16, 2024
·
6 min read
·
Kate Goodwin
Biotech Beach
Molecular Assemblies Launches Partner Program for Onsite Synthesis of Long, Pure, Accurate DNA
Molecular Assemblies, Inc., a pioneer and leader in the field of enzymatic DNA synthesis, announced the launch of its Partnering Program to license Molecular Assemblies’ Fully Enzymatic SynthesisTM technology for onsite synthesis.
May 7, 2024
·
4 min read
Press Releases
Alveo Technologies and Fraunhofer Partner to Develop First-of-its-Kind Rapid, Molecular Feline Respiratory Panel Diagnostic
December 11, 2024
·
3 min read
Earnings
Biogen Tops Wall Street Expectations for Leqembi, Inks Molecular Glue Deal
Biogen touted strong Q3 sales of its Alzheimer’s drug Leqembi a day after announcing a deal worth up to $1.45 billion with Neomorph to discover and develop molecular glue degraders.
October 30, 2024
·
2 min read
·
Heather McKenzie
Press Releases
Precision for Medicine and Agena Bioscience Announce Strategic Partnership and Breakthrough Findings at Association for Molecular Pathology 2024 Annual Meeting & Expo
November 20, 2024
·
4 min read
Collaboration
Novartis Inks Potential $2.2B Molecular Glue Deal With Monte Rosa
The Swiss pharma is paying $150 million upfront to gain rights to Monte Rosa’s VAV1-targeting molecular glue degraders, led by a Phase I candidate which holds therapeutic promise for immune-mediated diseases.
October 28, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Alveo Technologies Launches Academic Partnership Program to Drive Innovation in Point-of-Need Molecular Diagnostics with Global Virus Network as Inaugural Partner
September 27, 2024
·
5 min read
Business
Io Therapeutics, Inc., presented data from studies of IRX4204, the company’s phase II clinical stage RXR agonist for treatment of normal aging-related neurodegeneration, at the FASEB Science Research Conference on Cellular and Molecular Mechanisms of Brain Aging
September 18, 2024
·
3 min read
Cayman Chemical Expands Molecular Diagnostic Research Offerings Through Partnership with PCRassays.com
Cayman Chemical, a leading supplier of research tools for the life science community, has widened their portfolio to include molecular-based detection kits through a strategic partnership with PCRassays.com.
June 6, 2024
·
2 min read
Business
Takeda Joins Hot Molecular Glue Market With $1.2B Deal
Riding the growing wave of interest in molecular glue degraders, Takeda has partnered with Chinese biotech Degron Therapeutics to develop novel therapies for oncology, neuroscience and inflammation.
May 23, 2024
·
2 min read
·
Tristan Manalac
1 of 50,037
Next
